ZA966760B - (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate. - Google Patents

(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate.

Info

Publication number: ZA966760B
Authority: ZA; South Africa
Prior art keywords: phenylpiperidin; hydroxyphenyl; hydroxy; propanol methanesulfonate; methanesulfonate trihydrate
Prior art date: 1995-08-11

Application number

ZA9606760A

Other languages

English (en)

Inventor

Marta Maria Andino

Terry Gene Sinay

Eugene Fred Fiese

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-11

Filing date

1996-08-08

Publication date

1998-02-09

1996-08-08 Application filed by Pfizer filed Critical Pfizer

1998-02-09 Publication of ZA966760B publication Critical patent/ZA966760B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Diabetes (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)

ZA9606760A 1995-08-11 1996-08-08 (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate. ZA966760B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US223895P	1995-08-11	1995-08-11

Publications (1)

Publication Number	Publication Date
ZA966760B true ZA966760B (en)	1998-02-09

Family

ID=21699847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9606760A ZA966760B (en)	1995-08-11	1996-08-08	(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate.

Country Status (41)

Country	Link
US (1)	US6008233A (xx)
EP (1)	EP0843661B1 (xx)
JP (1)	JP3099072B2 (xx)
KR (1)	KR100291882B1 (xx)
CN (2)	CN1615861A (xx)
AP (1)	AP755A (xx)
AR (1)	AR004676A1 (xx)
AT (1)	ATE215072T1 (xx)
AU (1)	AU710984B2 (xx)
BG (1)	BG63678B1 (xx)
BR (1)	BR9610766A (xx)
CA (1)	CA2228752C (xx)
CO (1)	CO4750830A1 (xx)
CZ (1)	CZ296236B6 (xx)
DE (1)	DE69620191T2 (xx)
DK (1)	DK0843661T3 (xx)
DZ (1)	DZ2083A1 (xx)
ES (1)	ES2170857T3 (xx)
GT (1)	GT199600051A (xx)
HR (1)	HRP960372B1 (xx)
HU (1)	HUP9802862A3 (xx)
IL (1)	IL122649A (xx)
IS (1)	IS1945B (xx)
MA (1)	MA23957A1 (xx)
NO (1)	NO310458B1 (xx)
NZ (1)	NZ309134A (xx)
OA (1)	OA10664A (xx)
PE (1)	PE4898A1 (xx)
PL (1)	PL185603B1 (xx)
PT (1)	PT843661E (xx)
RO (1)	RO120134B1 (xx)
RS (1)	RS49521B (xx)
RU (1)	RU2140910C1 (xx)
SA (1)	SA96170171B1 (xx)
SK (1)	SK284209B6 (xx)
TN (1)	TNSN96104A1 (xx)
TR (1)	TR199800208T1 (xx)
TW (1)	TW495502B (xx)
UA (1)	UA59341C2 (xx)
WO (1)	WO1997007098A1 (xx)
ZA (1)	ZA966760B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2139857C1 (ru) *	1994-08-18	1999-10-20	Пфайзер Инк.	Производные 3-(пиперидинил-1)-хроман-4,7-диола и 1-(4-гидроксифенил)-2-(пиперидинил-1)-алканола, фармацевтическая композиция и способ связывания nmda рецептора
RU2140910C1 (ru) *	1995-08-11	1999-11-10	Пфайзер Инк.	Тригидрат метансульфоната (1s,2s)-1-(4-гидроксифенил)-2-(4-гидрокси-4- фенилпиперидин-1-ил)-1-пропанола
GB9820405D0 (en) *	1998-09-18	1998-11-11	Smithkline Beecham Plc	Process
WO2000061558A1 (en) *	1999-04-09	2000-10-19	Mochida Pharmaceutical Co., Ltd.	Remedies for neuropathic pain
GB9920919D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel compound
GB9920917D0 (en)	1999-09-03	1999-11-10	Sb Pharmco Inc	Novel process
US6620830B2 (en) *	2000-04-21	2003-09-16	Pfizer, Inc.	Thyroid receptor ligands
YU27701A (sh) *	2000-04-28	2003-04-30	Pfizer Products Inc.	Postupak za dobijanje trihidrata mezilatne soli 1-(4- hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)1-propanola
YU27801A (sh)	2000-04-28	2003-04-30	Pfizer Products Inc.	Postupak za dobijanje trihidrata mezilatne soli 1-(4- hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanola i korisnih intermedijera
NZ524741A (en)	2000-08-16	2005-01-28	Upjohn Co	Heterocyclic amines, phenylazacycloalkanes, cabergoline and aromatic bicyclic amines for the treatment of alcohol, nicotine and drug addiction
EP1186303A3 (en) *	2000-09-06	2003-12-10	Pfizer Products Inc.	Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist
IL145584A0 (en)	2000-10-02	2002-06-30	Pfizer Prod Inc	Nmda nr2b antagonists for treatment
EP1674087A1 (en)	2000-10-02	2006-06-28	Pfizer Products Inc.	Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
UA73619C2 (en) *	2000-12-13	2005-08-15	Pfizer Prod Inc	Stable pharmaceutical compositions of nmda receptor agonist (variants) and method of treatment
DE60220694T2 (de) *	2001-10-19	2008-02-07	Toyama Chemical Co. Ltd.	Alkyletherderivate oder deren salze
KR100517638B1 (ko)	2002-04-08	2005-09-28	주식회사 엘지생명과학	게미플록사신 산염의 새로운 제조방법
US8173642B2 (en)	2005-10-25	2012-05-08	Shionogi & Co., Ltd.	Aminodihydrothiazine derivatives
MX2009011498A (es)	2007-04-24	2009-11-10	Shionogi & Co	Derivados de aminodihidrotiazina sustituida con un grupo ciclico.
EP2151435A4 (en)	2007-04-24	2011-09-14	Shionogi & Co	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
KR101324426B1 (ko)	2008-06-13	2013-10-31	시오노기세야쿠 가부시키가이샤	β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
EP2360155A4 (en)	2008-10-22	2012-06-20	Shionogi & Co	2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
RU2012129168A (ru)	2009-12-11	2014-01-20	Сионоги Энд Ко. Лтд.	Производные оксазина
CN103261199A (zh)	2010-10-29	2013-08-21	盐野义制药株式会社	萘啶衍生物
JP5766198B2 (ja)	2010-10-29	2015-08-19	塩野義製薬株式会社	縮合アミノジヒドロピリミジン誘導体
JPWO2012147763A1 (ja)	2011-04-26	2014-07-28	塩野義製薬株式会社	オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
JP2016501827A (ja)	2012-10-24	2016-01-21	塩野義製薬株式会社	Ｂａｃｅ１阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体
SG11201701853YA (en)	2014-09-15	2017-04-27	Rugen Holdings Cayman Ltd	Pyrrolopyrimidine derivatives as nr2b nmda receptor antagonists
WO2016049048A1 (en) *	2014-09-22	2016-03-31	Rugen Holdings (Cayman) Limited	Treatment of anxiety disorders and autism spectrum disorders
EP3253761A4 (en)	2015-02-04	2018-06-20	Rugen Holdings (Cayman) Limited	3,3-difluoro-piperidine derivatives as nr2b nmda receptor antagonists
KR102613179B1 (ko)	2015-06-01	2023-12-14	뤼겐 홀딩스 (케이맨) 리미티드	Nr2b nmda 수용체 길항제로서의 3,3-디플루오로피페리딘 카바메이트 헤테로사이클릭 화합물
EP3544610A1 (en)	2016-11-22	2019-10-02	Rugen Holdings (Cayman) Limited	Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK232890A3 (en) *	1989-05-17	1998-11-04	Pfizer	2-piperidino and 2-pyrrolidino-1-alkanols derivatives and preparation method thereof
US5272160A (en) *	1989-05-17	1993-12-21	Pfizer Inc	2-piperidino-1-alkanol derivatives as antiischemic agents
RU2139857C1 (ru) *	1994-08-18	1999-10-20	Пфайзер Инк.	Производные 3-(пиперидинил-1)-хроман-4,7-диола и 1-(4-гидроксифенил)-2-(пиперидинил-1)-алканола, фармацевтическая композиция и способ связывания nmda рецептора
RU2140910C1 (ru) *	1995-08-11	1999-11-10	Пфайзер Инк.	Тригидрат метансульфоната (1s,2s)-1-(4-гидроксифенил)-2-(4-гидрокси-4- фенилпиперидин-1-ил)-1-пропанола

1996
- 1996-06-20 RU RU98102116A patent/RU2140910C1/ru not_active IP Right Cessation
- 1996-06-20 DK DK96916266T patent/DK0843661T3/da active
- 1996-06-20 UA UA98020673A patent/UA59341C2/uk unknown
- 1996-06-20 TR TR1998/00208T patent/TR199800208T1/xx unknown
- 1996-06-20 AT AT96916266T patent/ATE215072T1/de not_active IP Right Cessation
- 1996-06-20 HU HU9802862A patent/HUP9802862A3/hu unknown
- 1996-06-20 RO RO98-00231A patent/RO120134B1/ro unknown
- 1996-06-20 BR BR9610766A patent/BR9610766A/pt not_active Application Discontinuation
- 1996-06-20 KR KR1019980700989A patent/KR100291882B1/ko not_active Expired - Fee Related
- 1996-06-20 AU AU59084/96A patent/AU710984B2/en not_active Ceased
- 1996-06-20 DE DE69620191T patent/DE69620191T2/de not_active Expired - Fee Related
- 1996-06-20 CN CNA031584969A patent/CN1615861A/zh active Pending
- 1996-06-20 NZ NZ309134A patent/NZ309134A/en unknown
- 1996-06-20 EP EP96916266A patent/EP0843661B1/en not_active Expired - Lifetime
- 1996-06-20 PL PL96325050A patent/PL185603B1/pl not_active IP Right Cessation
- 1996-06-20 ES ES96916266T patent/ES2170857T3/es not_active Expired - Lifetime
- 1996-06-20 CN CN96195649A patent/CN1198739A/zh active Pending
- 1996-06-20 SK SK166-98A patent/SK284209B6/sk unknown
- 1996-06-20 JP JP09509083A patent/JP3099072B2/ja not_active Expired - Fee Related
- 1996-06-20 CA CA002228752A patent/CA2228752C/en not_active Expired - Fee Related
- 1996-06-20 CZ CZ0039098A patent/CZ296236B6/cs not_active IP Right Cessation
- 1996-06-20 PT PT96916266T patent/PT843661E/pt unknown
- 1996-06-20 WO PCT/IB1996/000592 patent/WO1997007098A1/en not_active Ceased
- 1996-06-20 IL IL12264996A patent/IL122649A/xx not_active IP Right Cessation
- 1996-06-20 US US09/011,426 patent/US6008233A/en not_active Expired - Fee Related
- 1996-06-24 TW TW085107571A patent/TW495502B/zh not_active IP Right Cessation
- 1996-07-04 GT GT199600051A patent/GT199600051A/es unknown
- 1996-07-23 SA SA96170171A patent/SA96170171B1/ar unknown
- 1996-08-06 PE PE1996000587A patent/PE4898A1/es not_active Application Discontinuation
- 1996-08-07 DZ DZ960127A patent/DZ2083A1/fr active
- 1996-08-07 AR ARP960103904A patent/AR004676A1/es unknown
- 1996-08-07 MA MA24335A patent/MA23957A1/fr unknown
- 1996-08-07 TN TNTNSN96104A patent/TNSN96104A1/fr unknown
- 1996-08-08 AP APAP/P/1996/000856A patent/AP755A/en active
- 1996-08-08 ZA ZA9606760A patent/ZA966760B/xx unknown
- 1996-08-09 CO CO96042164A patent/CO4750830A1/es unknown
- 1996-08-09 HR HR960372A patent/HRP960372B1/xx not_active IP Right Cessation
- 1996-08-09 RS YU46196A patent/RS49521B/sr unknown
1997
- 1997-12-30 IS IS4643A patent/IS1945B/is unknown
1998
- 1998-02-10 OA OA9800021A patent/OA10664A/en unknown
- 1998-02-10 NO NO19980574A patent/NO310458B1/no unknown
- 1998-02-27 BG BG102289A patent/BG63678B1/bg unknown

Also Published As

Publication number	Publication date
EP0843661A1 (en)	1998-05-27
MA23957A1 (fr)	1997-04-01
DE69620191T2 (de)	2002-07-18
PT843661E (pt)	2002-07-31
AU5908496A (en)	1997-03-12
KR100291882B1 (ko)	2001-10-26
UA59341C2 (uk)	2003-09-15
CO4750830A1 (es)	1999-03-31
NO310458B1 (no)	2001-07-09
BG63678B1 (bg)	2002-09-30
AP9600856A0 (en)	1996-10-31
SA96170171B1 (ar)	2006-05-20
HUP9802862A3 (en)	1999-05-28
DE69620191D1 (de)	2002-05-02
ATE215072T1 (de)	2002-04-15
RS49521B (sr)	2006-10-27
SK284209B6 (en)	2004-11-03
TW495502B (en)	2002-07-21
JP3099072B2 (ja)	2000-10-16
KR19990036321A (ko)	1999-05-25
AP755A (en)	1999-08-02
MX9801149A (es)	1998-05-31
HUP9802862A2 (hu)	1999-04-28
DZ2083A1 (fr)	2002-10-23
CZ296236B6 (cs)	2006-02-15
NO980574D0 (no)	1998-02-10
CA2228752C (en)	2002-12-10
BR9610766A (pt)	1999-07-13
IS4643A (is)	1997-12-30
CN1615861A (zh)	2005-05-18
WO1997007098A1 (en)	1997-02-27
TNSN96104A1 (fr)	2005-03-15
IL122649A0 (en)	1998-08-16
PL325050A1 (en)	1998-07-06
GT199600051A (es)	1997-12-26
AU710984B2 (en)	1999-10-07
ES2170857T3 (es)	2002-08-16
IL122649A (en)	2001-08-26
JPH10510552A (ja)	1998-10-13
CZ39098A3 (cs)	1999-02-17
CN1198739A (zh)	1998-11-11
HRP960372B1 (en)	2003-04-30
RO120134B1 (ro)	2005-09-30
IS1945B (is)	2004-08-13
SK16698A3 (en)	1999-06-11
RU2140910C1 (ru)	1999-11-10
US6008233A (en)	1999-12-28
OA10664A (en)	2000-11-06
DK0843661T3 (da)	2002-07-22
NO980574L (no)	1998-02-10
PL185603B1 (pl)	2003-06-30
HRP960372A2 (en)	1998-04-30
PE4898A1 (es)	1998-03-16
TR199800208T1 (xx)	1998-05-21
CA2228752A1 (en)	1997-02-27
YU46196A (xx)	1999-07-28
BG102289A (en)	1998-09-30
AR004676A1 (es)	1999-03-10
EP0843661B1 (en)	2002-03-27
NZ309134A (en)	1999-09-29

Publication	Publication Date	Title
ZA966760B (en)	1998-02-09	(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-Hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate.
MX194138B (es)	1999-11-18	Tintes azoicos de imidazol cationicos.
ZA985875B (en)	2000-01-10	Azetidines.
AU2349795A (en)	1995-11-29	Connector for wires, etc.
ZA971285B (en)	1997-08-27	Cationic detergent compounds.
CY2333B1 (en)	2004-02-06	10-Aminoaliphatyl-dibenz (b,f) oxepins with antineur odegenarative activity.
ZA966773B (en)	1997-02-19	Sulfonyl-or sulfinyl-benzoylguanidin derivate.
GB9824177D0 (en)	1998-12-30	Take out mechanism for an i.s machine
ZA962753B (en)	1997-10-06	1,3-Dihydro-2H-imidazol-2-one derivatives.
ZA9710212B (en)	1998-06-03	Thermal barrier for a primary pump.
ZA974950B (en)	1997-12-29	N-acetonylbenzamide fungicides.
ZA969796B (en)	1998-05-22	Fungicidal compounds.
GB2289775B (en)	1998-07-08	I.S Machine
GB9824172D0 (en)	1998-12-30	I.S. machine
GB9513892D0 (en)	1995-09-06	Brush assembly for d.c. machine
ZA964565B (en)	1996-12-12	Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
GB9824196D0 (en)	1998-12-30	I.S.machine
ZA966778B (en)	1997-02-19	Filler for sliding gates.
GB9824195D0 (en)	1998-12-30	I.s. machine
SI0843661T1 (en)	2002-06-30	(1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
ZA969127B (en)	1998-04-30	Fungicidal compounds.
ZA976694B (en)	1998-06-15	Fungicides.
EP0669375A3 (en)	1996-04-24	Polymer blends.
ZA981988B (en)	1999-09-09	Packaging machine.
IT1269022B (it)	1997-03-18	Tappo per operazioni di sfecciatura.